London Daily

Focus on the big picture.
Wednesday, Jul 30, 2025

GP staff facing abuse from patients over cancelled blood tests

GP staff facing abuse from patients over cancelled blood tests

Cancellation of all but clinically urgent blood tests in England owing to shortage of bottles sparks anger
GP surgery staff are facing abuse from patients who are “angry and upset” that their blood test has been cancelled because of the NHS-wide chronic shortage of sample bottles.

“Patients are angry when we ring them up and say, ‘Sorry we can’t do your blood test after all’. A lot of people are quite angry and concerned about their own health,” Dr David Wrigley, the deputy chair of council at the British Medical Association, said.

“Patients are quite rightly upset and some get quite aggressive as well. They are worried because they don’t know what the implications of their cancelled test are for their health.”

Wrigley said patients were also anxious about the cancellations of the flu jab, as the Guardian reported last week.

GP practices in England had begun cancelling appointments because the NHS’s main supplier could not deliver stocks as planned for one to two weeks because of “unforeseen road freight challenges”. Staff were “exasperated” to be on the receiving end of such hostility, he added.

Wrigley, a GP in Lancashire, tweeted last week: “My surgery staff are at their wits’ end. Due to the blood bottle shortage having to cancel ‘non-urgent’ tests. When our staff call patients they are getting abuse and anger directed at them. This is NOT our fault.”

NHS England has responded to the shortage of blood sample bottles by telling GPs to cancel all but clinically urgent blood tests and hospitals to cut back the tests they do by at least 25%. The sudden lack of them has arisen because Becton Dickinson, the NHS’s main supplier, is unable to make promised deliveries.

It has blamed that on a number of factors including unprecedented demand, “transportation challenges” and a two-week shutdown at its factory in Plymouth.

While Wrigley stressed that only a minority of patients were responding with hostility to hearing their blood test had been cancelled, “with flu cancellations on top this creates more antipathy towards general practice, when [these shortages] are totally out of our control. Patients are rightly anxious and upset about cancellations.”

NHS England has told GPs and hospitals to severely limit blood tests until 17 September. However, fears are growing that the shortage will continue into the autumn. Cardiff and Vale University health board wrote to staff last week warning that it might run out of sample bottles due to “the criticality of the urgent national supply issues of blood sampling collection tubes”.

It added: “This urgent stock issue is expected to extend into November, and based on the organisation’s typical usage of these products the current stocks available to us will not be sufficient to met demand.”

Becton Dickinson has brought in 9m bottles from the US as an emergency measure to alleviate the situation and handed them over to the NHS. However, it is not clear when they will be distributed and in what numbers. It has also boosted production in Plymouth by 20%.

A spokesperson for the firm said: “We expect the situation to stabilise and recover through September, based on the volume of tubes we are supplying to the NHS.”

Wrigley said GPs had been put “in a very, very difficult situation” by now having to decide which patients get a blood test and which do not. While some tests can be delayed fairly easily, delaying others – such as to decide what medication someone is on for a long-term condition – could pose a risk to the patient.

An NHS spokesperson said: “NHS staff should never be subjected to verbal or physical abuse for doing their job and the NHS will not tolerate abuse, aggression or violence.

“While Becton Dickinson has confirmed the current global supply issue will mean constraint will be temporary, it is vital that GPs and hospitals continue to follow the guidance until further advised, so patients with the most urgent need can be sure of a test.”
Newsletter

Related Articles

0:00
0:00
Close
Former Judge Charged After Drunk Driving Crash Kills Comedian in Brazil
Jeff Bezos hasn’t paid a dollar in taxes for decades. He makes billions and pays $0 in taxes, LEGALLY
China Increases Use of Exit Bans Amid Rising U.S. Tensions
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
Procter & Gamble to Raise U.S. Prices to Offset One‑Billion‑Dollar Tariff Cost
House Republicans Move to Defund OECD Over Global Tax Dispute
Botswana Seeks Controlling Stake in De Beers as Anglo American Prepares Exit
Trump Administration Proposes Repeal of Obama‑Era Endangerment Finding, Dismantling Regulatory Basis for CO₂ Emissions Limits
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
A family has been arrested in the UK for displaying the British flag
Mel Gibson refuses to work with Robert De Niro, saying, "Keep that woke clown away from me."
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
The British propaganda channel BBC News lies again.
Deputy attorney general's second day of meeting with Ghislaine Maxwell has concluded
Controversial March in Switzerland Features Men Dressed in Nazi Uniforms
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
Thai Civilian Death Toll Rises to 12 in Cambodian Cross-Border Attacks
TSUNAMI: Trump Just Crossed the Rubicon—And There’s No Turning Back
Over 120 Criminal Cases Dismissed in Boston Amid Public Defender Shortage
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
Trump Announces $550 Billion Japanese Investment and New Trade Agreements with Indonesia and the Philippines
US Treasury Secretary Calls for Institutional Review of Federal Reserve Amid AI‑Driven Growth Expectations
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Severe Flooding in South Korea Claims Lives Amid Ongoing Rescue Operations
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
CEO Resigns Amid Controversy Over Relationship with HR Executive
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
×